# PRIMARY BILIARY CIRRHOSIS

Interlobular bile ducts are damaged by chronic autoimmune granulomatous inflammation causing cholestasis which may lead to fibrosis, cirrhosis and portal hypertension.

Prevalence: <4/100,000

F:M ~ 9:1

Typical age at presentation ~50y.

### CAUSES

Unknown environmental triggers + genetic predisposition leading to loss of immune tolerance to self-mitochondrial proteins.

**Antimitochondrial antibodies** are the hallmark of PBC.


### RISK FACTORS

- family history

- many UTIs

- smoking

- past pregnancy

- other autoimmune disease

- high use of nail polish/hair dye

### SIGNS + SYMPTOMS

Often asymptomatic + dx after routine LFT showing high ALP.

Initial signs + symptoms (may precede jaundice by years):

- lethargy

- sleepiness

- pruritis

Signs:

- jaundice

- skin pigmentation

- xanthelasma

- xanthomata

- hepatosplenomegaly

### COMPLICATIONS

Cirrhosis + associated complications.

Osteoporosis common.

Malabsorption of fat-soluble vitamines A, D, E, K due to cholestasis + low bilirubin in gut lumen.

Leads to osteomalacia + coagulopathy.

Hepatocellular carcinoma: check AFP yearly.

### INVESTIGATIONS

**Bloods**:

- ALP high

- gamma GT high

- AST/ALT mildly raised

- late disease:

	- bilirubin high

	- albumin low

	- prothrombin time high
	
98% AMA M2 subtype +ve.

Immunoglobulins raised.

TSH + cholesterol raised or normal.

**Ultrasound** excludes extrahepatic cholestasis.

Biopsy: not usually needed. Look for granulomas around bile ducts Â± cirrhosis.

#### LIVER GRANULOMA DDx

- sarcoidosis

- PBC

- TB

- parasites/schistosomiasis

- brucellosis

- drug reactions

### MGMT

#### SYMPTOMATIC

Pruritis:

- **colestyramine** 4-8g/24h PO
- **naltrexone** + **rifampicin**

Diarrhoea: **codeine phosphate** e.g. 30mg/8h PO.

Osteoporosis prevention.

#### SPECIFIC

Fat-soluble vitamin prophylaxis: vitamin A, D and K.

Consider high dose **ursodeoxycholic acid** (UDCA).

- if baseline bilirubin >24 umol/L may improve survivial + delay transplantation

- predictors of good response:
	
	- ALP normalising/reducing to 40% baseline
	
	- bilirubin falling to <17
	
#### MONITORING

- regular lFT

- ultrasound

- AFP

#### LIVER TRANSPLANT

For end stage disease of intractable pruritis.

Histological recurrence in the graft ~17% after 5y.

Graft failure can fail due to recurrence but is rare and unpredictable.

### PROGNOSIS

Once jaundice develops, survivial <2y w/o transplant.